Immunosuppression with sirolimus, cyclosporyne, and prednisone in renal transplantation.
Gonzalez-Posada
J M
JM
Nephrology Unit, Hospital Universitario de Canarias, Sta Cruz de Tenerife, Spain.
Rodriguez
A P
AP
Pérez-Tamajón
L
L
Hdez-Marrero
D
D
Maceira
B
B
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001424:Bacterial Infections / Q000453:epidemiology; D002784:Cholesterol / Q000097:blood; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D018579:Patient Selection; D011183:Postoperative Complications / Q000145:classification / Q000453:epidemiology; D011241:Prednisone / Q000627:therapeutic use*; D020123:Sirolimus / Q000627:therapeutic use*; D013997:Time Factors; D014184:Transplantation, Homologous; D017211:Treatment Failure; D016896:Treatment Outcome; D014280:Triglycerides / Q000097:blood
D000924:Anticholesteremic Agents; D007166:Immunosuppressive Agents; D014280:Triglycerides; D016572:Cyclosporine; D002784:Cholesterol; D011241:Prednisone; D020123:Sirolimus